Cure My Disease

Don't miss your cure!

 Log in / Sign up

Canadian study tracks how psoriasis treatment affects work and Well-Being

NCT ID NCT05132231

Ongoing Disease control Sponsor: Bausch Health Americas, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is observing adults in Canada who are starting the psoriasis medication brodalumab as part of their regular care. Researchers will follow about 500 participants for one year to see how the treatment affects their quality of life, work productivity, and daily activities. The goal is to gather real-world information on the benefits and challenges of using this medication outside of a controlled clinical trial.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CARE Site 03

    Saskatoon, Saskatchewan, S7T 0G3, Canada

  • CARE Site 04

    Montreal, Quebec, H2E 1V4, Canada

  • CARE Site 05

    Barrie, Ontario, L4M 7G1, Canada

  • CARE Site 06

    Greater Sudbury, Ontario, P3C 1XB, Canada

  • CARE Site 07

    Laval, Quebec, H7N 6L2, Canada

  • CARE Site 09

    London, Ontario, N6H 5L6, Canada

  • CARE Site 11

    Ajax, Ontario, L1S 7K8, Canada

  • CARE Site 12

    Winnipeg, Manitoba, R3M 3Z4, Canada

  • CARE Site 13

    Richmond Hill, Ontario, L4C 9M7, Canada

  • CARE Site 14

    Hamilton, Ontario, L8N 1Y2, Canada

  • CARE Site 15

    Calgary, Alberta, T5J 3S9, Canada

  • CARE Site 16

    Toronto, Ontario, M5A 3R6, Canada

  • CARE Site 17

    Québec, Quebec, G3K 2P8, Canada

  • CARE Site 18

    Edmonton, Alberta, T5J 3S9, Canada

  • CARE Site 20

    Guelph, Ontario, N1L 0B7, Canada

  • CARE Site 21

    Edmonton, Alberta, T6W 0J5, Canada

  • CARE Site 22

    London, Ontario, N6A 5R9, Canada

  • CARE Site 23

    London, Ontario, N6A 2C2, Canada

  • CARE Site 24

    Hamilton, Ontario, L9B 1K5, Canada

  • CARE Site 26

    Calgary, Alberta, T2W 4X9, Canada

  • CARE Site 27

    Oshawa, Ontario, L1H 1B9, Canada

  • CARE Site 28

    Sherwood Park, Alberta, T8H 0P1, Canada

  • CARE Site 30

    Québec, Quebec, G1W 4R4, Canada

  • CARE Site 31

    Vancouver, British Columbia, V5Z 1M9, Canada

  • CARE Site 32

    Whitby, Ontario, L1N 8M7, Canada

  • CARE Site 33

    Markham, Ontario, L3P 1X3, Canada

  • CARE Site 35

    Saint Johns, Newfoundland and Labrador, A1E 1V4, Canada

  • CARE Site 36

    Winnipeg, Manitoba, R3C 0N2, Canada

  • CARE Site 37

    Edmonton, Alberta, T6X 0N9, Canada

  • CARE Site 38

    Drummondville, Quebec, J2B 5L4, Canada

  • CARE Site 39

    Saint-Jérôme, Quebec, J7Z 7E2, Canada

  • CARE Site 40

    Westmount, Quebec, H3Z 2S6, Canada

  • CARE Site 41

    Edmonton, Alberta, T6G 1C3, Canada

  • CARE Site 42

    Calgary, Alberta, T2J 7E1, Canada

  • CARE Site 44

    Mississauga, Ontario, L4W 0C2, Canada

  • CARE Site 46

    Québec, Quebec, G1V T3, Canada

  • CARE Site 47

    Sherbrooke, Quebec, J1L 0H8, Canada

  • CARE Site 48

    North York, Ontario, M3B 0A7, Canada

  • CARE Site 49

    Toronto, Ontario, M2N 3A6, Canada

  • CARE Site 50

    Laval, Quebec, H7P K7, Canada

  • CARE Site 51

    Niagara Falls, Ontario, L2E 6A6, Canada

  • CARE Site 52

    Saint-Charles-Borromée, Quebec, J6E 4P6, Canada

Conditions

Explore the condition pages connected to this study.

PSORIASIS